Royal Bank of Canada’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Royal Bank of Canada's RXST Position: Q1 2026 in Review
Royal Bank of Canada reduced its RxSight (RXST) stake by 36% in Q1 2026, selling an estimated $58.2K and leaving 12,302 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.
Royal Bank of Canada first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Royal Bank of Canada held 12,302 shares of RxSight worth $76K as of Q1 2026.
- Royal Bank of Canada sold 7,005 RxSight shares in Q1 2026, an estimated $58.2K.
- RxSight made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5280 holding.
- Royal Bank of Canada first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- Royal Bank of Canada's RxSight position peaked at $17.5M in Q4 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.